BENGALURU, May 11 (Reuters) - India's Dr. Lal PathLabs Ltd (DLPA.NS), opens new tab on Thursday reported a sixth consecutive fall in quarterly profit as a continued slide in income from COVID-related ...
Agreement expands Cardio Diagnostics' global footprint and supports improved detection and management of coronary heart disease in India.
Hosted on MSN
Dr Lal PathLabs reports 16% rise in Q2 profit, declares Rs.7 interim dividend and 1:1 bonus issue
Mumbai, Oct. 31 -- Dr Lal PathLabs Limited reported consolidated revenue of Rs.731 crore for the second quarter of FY2025-26, marking a 10.7% year-on-year increase, while profit after tax (PAT) rose ...
India's Dr Lal Path Labs beats quarterly profit view on medical testing boom Dr Lal Path Labs , India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback